business / news / / scanx.trade
Procter & Gamble Health Limited reported a 30% rise in Profit After Tax (PAT) for the financial year ended March 31, 2026.
Procter & Gamble Health changed its financial year end from June 30 to March 31 starting FY26.
KEY POINTS
- For FY26, PAT rose 30% to ₹327 crore and revenue increased 16% to ₹1,385 crore.
- Total dividend payout for FY26 is ₹205 per share, including a ₹160 interim and ₹45 final dividend.
- Board approved re-appointment of Mr. S. Madhavan as Independent Director for five years from November 15, 2026.
- New product launches included Livogen Iron Gummies and Neurobion Nerve Pain Relief Cream during FY26.
COMPANIES
Summarized by Newsio from scanx.trade. How we summarize →